Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell LymphomasRyan D. Morin, Nathalie A. Johnson, Qiang Pan‐Hammarström et al.|Clinical Cancer Research|2015Cited by 228
Abstract 3888: Molecular profiling of sequential biopsies in patients with metastatic colorectal cancer identifies genomic alterations that evolve during first-line therapy and could have therapeutic implications: A prospective study to identify molecular mechanisms of clinical resistance (QCROC-01: NCT00984048).Suzan McNamara, Gerald Batist, Ryan D. Morin et al.|Cancer Research|2015Cited by 0
Supplemental Materials from Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell LymphomasRyan D. Morin, Nathalie A. Johnson, Sarit Assouline et al.|Unknown|2023Cited by 0
Supplemental Table S6 from Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell LymphomasRyan D. Morin, Nathalie A. Johnson, Sarit Assouline et al.|Unknown|2023Cited by 0
Supplemental Table S4 from Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell LymphomasRyan D. Morin, Nathalie A. Johnson, Sarit Assouline et al.|Unknown|2023Cited by 0